Zurück

Wählen Sie Ihre Region

Corporate

Europa:

Flagge Albanien Albanien Flagge Bosnien-Herzegowina Bosnien-Herzegowina Flagge Bulgarien Bulgarien Flagge Kroatien Kroatien Flagge Zypern Zypern Flagge Montenegro Montenegro Flagge Tschechien Tschechien Flagge Dänemark Dänemark Flagge Estland Estland Flagge Spanien Spanien Flagge Kosovo Kosovo Flagge Litauen Litauen Flagge Lettland Lettland Flagge Luxemburg Luxemburg Flagge Mazedonien Mazedonien Flagge Deutschland Deutschland Flagge Polen Polen Flagge Portugal Portugal Flagge Rumänien Rumänien Flagge Serbien Serbien Flagge Slowakei Slowakei Flagge Slowenien Slowenien Flagge Schweiz Schweiz Flagge Schweden Schweden Flagge Türkei Türkei Flagge Ungarn Ungarn Flagge Großbritannien Großbritannien Flagge Italien Italien

Asien:

Flagge UAE UAE Flagge Hong Kong Hong Kong Flagge Kuwait Kuwait Flagge Libanon Libanon

Afrika:

Flagge Südafrika Südafrika

Vereinbaren Sie ein Beratungsgespräch über Stammzellen

Mehr erfahren

Kontaktieren Sie uns noch heute!

Möchten Sie mehr über unsere Dienstleistungen erfahren? Füllen Sie das untenstehende Formular aus, und wir werden uns so schnell wie möglich mit Ihnen in Verbindung setzen, um Ihnen alle notwendigen Informationen zu geben und Ihre Fragen zu beantworten.

    Wir möchten Sie darauf hinweisen, dass die im Formular angegebenen personenbezogenen Daten von FamiCord Suisse mit Sitz in der Schweiz (BusinessPark Zug Sumpfstrasse 26, 6302 Zug) zur telefonischen Kontaktaufnahme im Zusammenhang mit der Erteilung von Serviceinformationen verarbeitet werden.

    Obraz

    Unsere
    Transplantationen

    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:

    Obraz
    Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:
    Nr. Quelle Quellentyp Diagnose Medizinbereich Anwendungsjahr Therapie Land Alter des Empfängers
    7101 Apheresis Autologous B-Cell Non-Hodgkin Lymphoma – Relapse Hematology 2017 Standard Therapy Germany 68
    7102 Apheresis Allogeneic Blastic Plasmacytoid Dendritic Cell Neoplasm Hematology 2017 Standard Therapy Poland 56
    7103 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2017 Standard Therapy Poland 57
    7104 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2017 Standard Therapy Poland 45
    7105 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2017 Standard Therapy Poland 47
    7106 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2017 Standard Therapy Poland 67
    7107 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2017 Standard Therapy Poland 65
    7108 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2017 Standard Therapy Poland 51
    7109 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2017 Standard Therapy Poland 7
    7110 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2017 Standard Therapy Germany 31
    7111 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2017 Standard Therapy Poland 29
    7112 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2017 Standard Therapy Poland 74
    7113 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2017 Standard Therapy Poland 57
    7114 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2017 Standard Therapy Poland 54
    7115 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2017 Standard Therapy Poland 58
    7116 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2017 Standard Therapy Poland 51
    7117 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2017 Standard Therapy Poland 61
    7118 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2017 Standard Therapy Poland 72
    7119 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2017 Standard Therapy Poland 60
    7120 Apheresis Allogeneic Chronic Myeloproliferative Neoplasm Blast Crisis Hematology 2017 Standard Therapy Poland 29
    7121 Apheresis Allogeneic Common Variable Immunodeficiency, Relapsed Hemophagocytic Syndrome Hematology 2017 Standard Therapy Poland 44
    7122 Apheresis Allogeneic Diffuse Large B-Cell Lymphoma Hematology 2017 Standard Therapy Poland 61
    7123 Apheresis Allogeneic Diffuse Large B-Cell Lymphoma Hematology 2017 Standard Therapy Germany 41
    7124 Apheresis Autologous Diffuse Large B-Cell Lymphoma – Relapse Hematology 2017 Standard Therapy Germany 67
    7125 Apheresis Autologous Follicular B-Cell Non-Hodgkin-Lymphoma Grade I-II Relapse Hematology 2017 Standard Therapy Germany 59
    7126 Apheresis Allogeneic Follicular Ca Hematology 2017 Standard Therapy Poland 42
    7127 Apheresis Autologous Follicular Lymphoma Hematology 2017 Standard Therapy Germany 47
    7128 Apheresis Allogeneic Hemophagocytosis Hematology 2017 Standard Therapy Poland 52
    7129 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2017 Standard Therapy Poland 25
    7130 Apheresis Allogeneic Langerhans Lymphohistiocytosis Hematology 2017 Standard Therapy Poland 2
    7131 Apheresis Autologous Light-Chain Myeloma Hematology 2017 Standard Therapy Germany 62
    7132 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 58
    7133 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 63
    7134 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 61
    7135 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 64
    7136 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 59
    7137 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 68
    7138 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 50
    7139 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 56
    7140 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 62
    7141 Apheresis Autologous Mantle Cell Lymphoma Hematology 2017 Standard Therapy Germany 53
    7142 Apheresis Allogeneic Morbus Hodgkin Hematology 2017 Standard Therapy Germany 38
    7143 Apheresis Autologous Morbus Hodgkin Hematology 2017 Standard Therapy Germany 60
    7144 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 61
    7145 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 65
    7146 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
    7147 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 61
    7148 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 60
    7149 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 58
    7150 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 61
    7151 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 63
    7152 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 58
    7153 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 72
    7154 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 63
    7155 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 50
    7156 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 52
    7157 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 72
    7158 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 57
    7159 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 56
    7160 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 59
    7161 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
    7162 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 72
    7163 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 69
    7164 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 52
    7165 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 67
    7166 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
    7167 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
    7168 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 50
    7169 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 67
    7170 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 53
    7171 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 62
    7172 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 44
    7173 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 62
    7174 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 56
    7175 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 60
    7176 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
    7177 Apheresis Autologous Multiple Myeloma Hematology 2017 Standard Therapy Germany 64
    7178 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 60
    7179 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 3
    7180 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 56
    7181 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 54
    7182 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 75
    7183 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 64
    7184 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 64
    7185 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 46
    7186 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 53
    7187 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 71
    7188 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 50
    7189 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
    7190 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 67
    7191 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 65
    7192 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 68
    7193 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 59
    7194 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
    7195 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 69
    7196 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 54
    7197 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 65
    7198 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 63
    7199 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 54
    7200 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2017 Standard Therapy Poland 49